To include your compound in the COVID-19 Resource Center, submit it here.

Kiobrina: Phase II data

Data from a double-blind, crossover, French and Italian Phase II trial in

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE